Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy

Area of Science:

• Oncology
• Biomedical Engineering
• Nanotechnology

Background:

• Platelets are increasingly recognized for their role beyond hemostasis, actively participating in tumor progression, including invasion and metastasis.
• Traditional platelet-based anti-tumor drugs face challenges due to lack of targeting, leading to autologous platelet damage and adverse effects.

Purpose of the Study:

• To review recent advancements in understanding the crosstalk between platelets and tumors.
• To explore the progress of platelet-based nanoparticle drug delivery systems for anti-tumor therapy.

Main Methods:

• Literature review of studies on platelet-tumor interactions.
• Analysis of novel platelet-based nanoparticle designs and their targeting strategies.
• Examination of special response modes in drug delivery systems.

Main Results:

• Platelets are integral to multiple stages of tumor progression.
• Platelet-targeting or platelet membrane-coated nanoparticles demonstrate enhanced anti-tumor effects.
• Specialized response modes in nanoparticles improve targeting and therapeutic outcomes.

Conclusions:

• Platelet-tumor interactions offer significant therapeutic potential.
• Platelet-based nanoparticles represent a promising strategy for targeted cancer drug delivery.
• Further research into platelet-based nanomedicine can lead to improved anti-tumor therapies with reduced toxicity.